Cargando…

Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review

The knowledge on thyroid cancer biology has grown over the past decade. Thus, diagnostic and therapeutic strategies to manage thyroid cancer are rapidly evolving. With new insights into tumor biology and cancer genetics, several novel therapies have been approved for the treatment of thyroid cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Jundi, Mohammad, Thakur, Shilpa, Gubbi, Sriram, Klubo-Gwiezdzinska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463725/ https://www.ncbi.nlm.nih.gov/pubmed/32751138 http://dx.doi.org/10.3390/cancers12082104

Ejemplares similares

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

A Unique Presentation of Metastatic Follicular Thyroid Cancer Associated with Hyperthyroidism and an Active Graves’ Orbitopathy
por: Al-Jundi, Mohammad, et al.
Publicado: (2021)

OR09-3 Integrins as Potential Molecular Targets in Thyroid Cancer Imaging and Therapy
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

SAT-502 Clinical Hypothyroidism Associated with Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma: A Novel Adverse Effect of Peptide Receptor Radionuclide Therapy
por: Gubbi, Sriram, et al.
Publicado: (2020)

The Role of Lithium in Management of Endocrine Tumors—A Comprehensive Review
por: Thakur, Shilpa, et al.
Publicado: (2019)

SAT556 An Unusual Case of Papillary Thyroid Carcinoma With Biallelic MEN1 Variants In a Patient With MEN1
por: Chuki, Elias, et al.
Publicado: (2023)

OR09-5 mTOR Signaling is Associated with Regulation of Mitochondrial Respiration in Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

MON-214 Biochemical Abnormalities in Endocrine Function Associated with Lutetium 177-DOTATATE Therapy in Metastatic Pheochromocytoma and Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2020)

Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
por: Gubbi, Sriram, et al.
Publicado: (2022)

SAT559 Challenges Involved in Managing a Paraplegic Patient with Metastatic Papillary Thyroid Cancer Requiring Radioactive Iodine Therapy
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)

SAT562 Metastatic Oncocytic (Formerly Hürthle Cell) Thyroid Carcinoma in a Patient With Birt-Hogg-Dubé Syndrome
por: Vaid, Sonal, et al.
Publicado: (2023)

The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function—A Comprehensive Review
por: Kumari, Sonam, et al.
Publicado: (2020)

Breathing the air of mitochondrial respiration via an important oncotarget - mitochondrial glycerophosphate dehydrogenase (mGPDH)
por: Thakur, Shilpa, et al.
Publicado: (2019)

Catecholamine physiology and its implications in patients with COVID-19
por: Gubbi, Sriram, et al.
Publicado: (2020)

FRI476 Asymptomatic Thyrotropin-secreting Pituitary Microadenoma With Biochemical Secondary Hyperthyroidism: A Diagnostic Conundrum
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)

SAT561 Pathogenic RET V804M Germline Variant Without Clinical Manifestations Of Multiple Endocrine Neoplasia Type 2 In An Elderly Male
por: Ghosh, Raisa, et al.
Publicado: (2023)

SAT519 Association of Free Thyroxine Level With Survival Outcome In Patients With Intermediate And High-Risk Differentiated Thyroid Cancer
por: Ghosh, Raisa, et al.
Publicado: (2023)

Editorial: Novel Imaging Techniques in the Management of Thyroid Nodules and Autoimmune Thyroid Disease
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2019)

SAT555 Utility of (18)F-DOPA PET/CT in the Diagnosis of Medullary Thyroid Cancer in a Patient with Multiple Endocrine Neoplasia Type 2B
por: Varghese, Diana Grace, et al.
Publicado: (2023)

PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome
por: Jumani, Sanjay, et al.
Publicado: (2022)

THYROID EMERGENCIES
por: Ylli, Dorina, et al.
Publicado: (2019)

SUN-553 Atypical Spindle Cells on a Thyroid Aspirate: A Rare Case of a Thyroid Schwannoma Presenting as a Progressively Expanding Thyroid Nodule
por: Gubbi, Sriram, et al.
Publicado: (2019)

Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

SAT521 Predictive Value of Tumor Volumetrics in Patients with Medullary Thyroid Cancer
por: Behairy, Noha, et al.
Publicado: (2023)

Hypertension and COVID-19: Updates from the era of vaccines and variants
por: Swamy, Sowmya, et al.
Publicado: (2021)

Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2022)

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study
por: Aswath, Kshama, et al.
Publicado: (2021)

Response to Letter to the Editor from Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2023)

Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [(177)Lu]Lu-DOTA-TATE therapy
por: Gubbi, Sriram, et al.
Publicado: (2023)

SUN-118 Somatostatin Agonist Conjugated to the Evans Blue Moiety Is a Superior Analog in the Diagnosis and Treatment of Tumors Characterized by High Somatostatin Receptor Expression
por: Thakur, Shilpa, et al.
Publicado: (2020)

Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer
por: Bikas, Athanasios, et al.
Publicado: (2020)

OR27-3 A Novel Risk Stratification System for Thyroid Nodules with Indeterminate Cytology: A Pilot Cohort Study
por: Gomes-Lima, Cristiane, et al.
Publicado: (2019)

SAT-575 Radiolabeled Somatostatin Receptor Analog (86)Y-EB-TATE is Characterized by Superior Tumor Uptake Compared to (68)Ga-DOTA-TATE and (68)Ga-DOTA-JR11 in Thyroid Cancer Mice Models
por: Thakur, Shilpa, et al.
Publicado: (2019)

Assessment of thyroid function tests and harmonization: opinion on thyroid hormone harmonization
por: Araque, Katherine A., et al.
Publicado: (2019)

Efficacy of Dosimetric Versus Empiric Prescribed Activity of (131)I for Therapy of Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
por: Luo, Hongxiu, et al.
Publicado: (2022)

A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology—A Pilot Cohort Study
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2020)

FRI355 Hypokalemia-induced Nephrogenic Diabetes Insipidus In A Patient With Medullary Thyroid Carcinoma And Paraneoplastic Cushing’s Syndrome
por: Jhawar, Sakshi, et al.
Publicado: (2023)

Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy
por: Jensen, Kirk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_06d1np5hafelam26krs16apajf